Avanir

Reeling from a hefty civil and criminal settlement, Avanir stumbles into PhIII Alzheimer's failure
Endpoints
Mon, 09/30/19 - 10:34 am
Avanir
Alzheimer's disease
clinical trials
Nuedexta
3 Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab Flop
Motley Fool
Sat, 03/30/19 - 12:44 pm
Alzheimer's disease
Biogen
aducanumab
Otsuka
Axsome Therapeutics
Amgen
Novartis
Avanir
AVP-786
AXS-05
AMG520
Users Respond to CNN article on Nuedexta
CP Wire
Fri, 10/13/17 - 09:45 am
CNN
Avanir
Nuedexta
cafepharma
The Best-Performing Biotechnology Stocks Of 2014
Forbes
Thu, 01/1/15 - 02:32 pm
biotech
Avanir
OvaScience
Agios
Bluebird Bio
Receptos
Prosensa
Pernix
Achillion
Amicus Therapeutics
CytoSorbents
PTC Therapeutics
Otsuka May Have Undervalued Avanir’s (AVNR) Bid; Shareholders Worried
Bidness Etc.
Fri, 12/5/14 - 11:01 am
Otsuka
M&A
Avanir
Japan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
Fortune
Tue, 12/2/14 - 08:39 am
Otsuka
M&A
Avanir
FDA rejects Avanir's migraine drug-device
Yahoo/Reuters
Wed, 11/26/14 - 11:33 pm
FDA
Avanir
migraines
AVP-825
FDA approval unlikely as PDUFA date approaches for Avanir
Seeking Alpha
Fri, 11/21/14 - 11:19 am
FDA
Avanir
migraines
AVP-825
Avanir's AVP-825 Approval Could be Delayed
Yahoo/Zacks.com
Wed, 11/12/14 - 08:35 am
Avanir
AVP-825
migraines
Avanir Inroads in Alzheimer’s Justify Offers: Real M&A
Bloomberg
Thu, 10/30/14 - 12:22 pm
M&A
Avanir
Alzheimer's disease
Lundbeck
Eli Lilly
Mallinckrodt
Shire
Avanir's Over-Priced Cough Syrup Touted For Role in Alzheimer's Agitation
TheStreet.com
Mon, 09/15/14 - 11:37 am
Avanir
Alzheimer's disease
AVP-923
Avanir Pharmaceuticals: Riding On A Non-Fundamental Catalyst
Seeking Alpha
Fri, 05/2/14 - 10:48 am
Avanir
Neudexta
Impax, Par Pharmaceutical stayed from selling generic version of Avanir drug
The Fly on the Wall
Wed, 03/19/14 - 11:05 am
Impax Laboratories
Avanir
generics
Par Pharmaceutical
Nuedexta
Avanir Pharmaceuticals' Revenue Soars 62% on Strong Nuedexta Sales
Motley Fool
Wed, 02/5/14 - 06:56 pm
earnings
Avanir
3 Companies Working on Parkinson's Treatments You Ought to Know About
Motley Fool
Wed, 01/29/14 - 05:42 pm
Parkinson's Disease
Chelsea Therapeutics
Prothena
Avanir
AVP-923
Northera
PRX-002
Piper Jaffray’s Seven Biotech Stocks to Buy With Huge Potential Upside
Wall St 24/7
Mon, 01/27/14 - 09:21 am
Avanir
BioDelivery Sciences
Conatus Pharmaceuticals
Geron
Halozyme
Neurocrine
Orexigen
Avanir Gives Preliminary Q1 Update
Yahoo/Zacks.com
Tue, 01/14/14 - 04:27 pm
Avanir
earnings
Biotechs With Near-Term Catalysts That Should Rally
Seeking Alpha
Fri, 01/10/14 - 10:34 am
Ampio
Avanir
Chelsea Therapeutics
Endo Health Solutions
Optina
Northera
Synergy Pharmaceuticals
plecanatide
AVP-825
vintafolide
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 09/14/13 - 11:01 am
Neurocrine Biosciences
ChemoCentryx
GSK
Avanir
Avanir, Sandoz settle Nuedexta patent litigation
Pharmaceutical Business Review
Fri, 08/16/13 - 10:55 am
Avanir
Sanzoz
patents
generics
Novartis
Nuedexta

Pages